Abstract Details
Erin G. Doty, MD
(Eli Lilly and Company)
PRESENTER |
Dr. Doty has received personal compensation for serving as an employee of Eli Lilly and Company, USA. Dr. Doty has stock in Eli Lilly and Company, USA. |
Messoud Ashina, MD, PhD (Dept. of Neurology) | Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. The institution of Dr. Ashina has received research support from The Lundbeck Foundation. Dr. Ashina has received publishing royalties from a publication relating to health care. |
Raghavendra Vasudeva, PhD | Dr. Vasudeva has received personal compensation for serving as an employee of Lilly. Dr. Vasudeva has stock in Lilly. |
No disclosure on file | |
Louise Lombard | Louise Lombard has received personal compensation for serving as an employee of Eli Lilly. |
No disclosure on file | |
No disclosure on file | |
No disclosure on file |